Follitropin alfa

促卵泡激素α

Report date: 2023/05/12 09:14:52

Base Information

Drug NameFollitropin alfa
Drug Alias Name促卵泡素Follitropin αFollitropin-alpha促滤泡素-a促卵泡素α +[16] 
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant hormone
Mechanisms of ActionFollicle-stimulating hormone receptor agonistsOvarian follicle stimulants
TargetsFollicle-stimulating hormone receptor
Therapy Area/IndicationsHypogonadismInfertility, FemaleAnovulation +[5] 
Global Approved IndicationsHypogonadismInfertility, FemaleAnovulation +[4] 
Approved Indications in ChinaHypogonadismInfertility
Original Approved Country/TerritoryEU
Original Approved Date1995/10/20
Country/TerritoryUnited StatesItalyGermany +[7] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesMerck Serono
China Registration ClassN/A

Develop Information

Active CompaniesEmd Serono IncMerck Europe BvMerck Serono +[4] 
Inactive CompaniesEunice Kennedy Shriver National Institute Of Child Health And Human DevelopmentIbsa Institut Biochimique SaEmd Serono Research & Development Institute Inc +[8] 
Active IndicationsHypogonadismInfertility, FemaleAnovulation +[4] 
Inactive IndicationsKallmann Syndrome

Other Information

ATC CodeG03GA05
Related LinksDrugBankKEGG